Compile Data Set for Download or QSAR

Found 4 hits of ic50 for monomerid = 203999   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Orexin receptor type 2 (Homo sapiens (Human))	BDBM203999 (2-{[(3r,6r)-1-{[4-methoxy-2- (2h-1,2,3-triazol-2- ...) Show SMILES COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2nccc(C#N)c2C)c(c1)-n1nccn1 |r| Show InChI InChI=1S/C23H24N6O3/c1-15-4-5-19(32-22-16(2)17(13-24)8-9-25-22)14-28(15)23(30)20-7-6-18(31-3)12-21(20)29-26-10-11-27-29/h6-12,15,19H,4-5,14H2,1-3H3/t15-,19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
Merck& Co. Curated by ChEMBL					Assay Description Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A a...				Bioorg Med Chem Lett 27: 1364-1370 (2017) Article DOI: 10.1016/j.bmcl.2017.02.012 BindingDB Entry DOI: 10.7270/Q2WH2S8Q
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM203999 (2-{[(3r,6r)-1-{[4-methoxy-2- (2h-1,2,3-triazol-2- ...) Show SMILES COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2nccc(C#N)c2C)c(c1)-n1nccn1 |r| Show InChI InChI=1S/C23H24N6O3/c1-15-4-5-19(32-22-16(2)17(13-24)8-9-25-22)14-28(15)23(30)20-7-6-18(31-3)12-21(20)29-26-10-11-27-29/h6-12,15,19H,4-5,14H2,1-3H3/t15-,19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
MERCK SHARP & DOHME CORP. US Patent					Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...				US Patent US9546152 (2017) BindingDB Entry DOI: 10.7270/Q2D50PZW
					More data for this Ligand-Target Pair
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human))	BDBM203999 (2-{[(3r,6r)-1-{[4-methoxy-2- (2h-1,2,3-triazol-2- ...) Show SMILES COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2nccc(C#N)c2C)c(c1)-n1nccn1 |r| Show InChI InChI=1S/C23H24N6O3/c1-15-4-5-19(32-22-16(2)17(13-24)8-9-25-22)14-28(15)23(30)20-7-6-18(31-3)12-21(20)29-26-10-11-27-29/h6-12,15,19H,4-5,14H2,1-3H3/t15-,19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	6.12E+3	n/a	n/a	n/a	n/a	n/a	n/a
Merck& Co. Curated by ChEMBL					Assay Description Antagonist activity at human OX1R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A a...				Bioorg Med Chem Lett 27: 1364-1370 (2017) Article DOI: 10.1016/j.bmcl.2017.02.012 BindingDB Entry DOI: 10.7270/Q2WH2S8Q
					More data for this Ligand-Target Pair
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human))	BDBM203999 (2-{[(3r,6r)-1-{[4-methoxy-2- (2h-1,2,3-triazol-2- ...) Show SMILES COc1ccc(C(=O)N2C[C@@H](CC[C@H]2C)Oc2nccc(C#N)c2C)c(c1)-n1nccn1 |r| Show InChI InChI=1S/C23H24N6O3/c1-15-4-5-19(32-22-16(2)17(13-24)8-9-25-22)14-28(15)23(30)20-7-6-18(31-3)12-21(20)29-26-10-11-27-29/h6-12,15,19H,4-5,14H2,1-3H3/t15-,19-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.12E+3	n/a	n/a	n/a	n/a	n/a	n/a
MERCK SHARP & DOHME CORP. US Patent					Assay Description The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...				US Patent US9546152 (2017) BindingDB Entry DOI: 10.7270/Q2D50PZW
					More data for this Ligand-Target Pair